Top of the page
PAX
CA - PAX immunotherapy
Molecular allergology is a state-of-the-art approach to the detection of sensitisations, whereby defined single allergen components are used for the determination of specific IgE in place of traditionally-used allergen extracts. The molecular components are recombinant proteins that provide a higher level of standardisation than allergen extracts and enable a more precise identification of IgE sensitisations. 

Molecular allergology tests are powerful tools that help pinpoint allergy triggers, thus facilitating risk assessment and therapy decisions. Nextmune is bringing you the first molecular allergology platform for animals, the next-generation in allergen IgE serology: PAX - Pet Allergy Xplorer
Description
Nextmune is bringing you the first molecular allergology platform for animals, the next-generation in allergen IgE serology: PAX - Pet Allergy Xplorer. 

What are the main advantages of PAX?
 
○ First quantitative multiplex macroarray specifically designed for companion animals 
○ Over 200 allergen extracts and components included = lower testing cost per allergen 
○ Fully automated process = higher level of standardization (same result if tested multiple times) 
○ With CCD blocking and 2 blocking efficiency detectors 
○ Only 0.5 ml of serum needed per test 
○ Expected increase in serological test sensitivity due to a higher concentration of molecular allergens ○ Identification of ”primary” sensitizing allergens 
○ Identification of allergen cross-reactivities
○ Selection of relevant allergens for specific immunotherapy 

The PAX results are clearly set out, easy to interpret and include the following information: 

○ Summary of detectable sensitizations 
○ Interpretation summary and treatment recommendation 
○ Detailed results per extract and components 
○ Detailed interpretation with Information about allergenicity and relevance, time of the year, possible cross-reactivities and treatment indication for each allergen
PAX
CA - PAX immunotherapy
Molecular allergology is a state-of-the-art approach to the detection of sensitisations, whereby defined single allergen components are used for the determination of specific IgE in place of traditionally-used allergen extracts. The molecular components are recombinant proteins that provide a higher level of standardisation than allergen extracts and enable a more precise identification of IgE sensitisations. 

Molecular allergology tests are powerful tools that help pinpoint allergy triggers, thus facilitating risk assessment and therapy decisions. Nextmune is bringing you the first molecular allergology platform for animals, the next-generation in allergen IgE serology: PAX - Pet Allergy Xplorer
Description
Nextmune is bringing you the first molecular allergology platform for animals, the next-generation in allergen IgE serology: PAX - Pet Allergy Xplorer. 

What are the main advantages of PAX?
 
○ First quantitative multiplex macroarray specifically designed for companion animals 
○ Over 200 allergen extracts and components included = lower testing cost per allergen 
○ Fully automated process = higher level of standardization (same result if tested multiple times) 
○ With CCD blocking and 2 blocking efficiency detectors 
○ Only 0.5 ml of serum needed per test 
○ Expected increase in serological test sensitivity due to a higher concentration of molecular allergens 
○ Identification of ”primary” sensitizing allergens 
○ Identification of allergen cross-reactivities
○ Selection of relevant allergens for specific immunotherapy 

The PAX results are clearly set out, easy to interpret and include the following information: 

○ Summary of detectable sensitizations 
○ Interpretation summary and treatment recommendation 
○ Detailed results per extract and components 
○ Detailed interpretation with Information about allergenicity and relevance, time of the year, possible cross-reactivities and treatment indication for each allergen